Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00029731
What this trial is testing

Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients

Who this might be right for
Anemia, Sickle CellPneumonia
UCSF Benioff Children's Hospital Oakland 30
Testing effectiveness (Phase 2)Looking for participantsNCT06635902
What this trial is testing

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode
Suvankar Majumdar 99
Not applicableEnrolling By InvitationNCT07624370
What this trial is testing

Frailty in the Elderly Oncological and Oncohematological Patient.

Who this might be right for
Sarcopenia in ElderlyFrailty/SarcopeniaOncological Patients+1 more
Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano 160
Not applicableStudy completedNCT01402869
What this trial is testing

Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local Anesthetics

Who this might be right for
Methemoglobinemia
Loma Linda University 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT04232241
What this trial is testing

Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid Leukemia in RemissionAcute Lymphoblastic Leukemia in RemissionMyelodysplastic Syndromes
Universitätsklinikum Hamburg-Eppendorf 167
Not applicableStudy completedNCT05376566
What this trial is testing

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

Who this might be right for
Central Line-associated Bloodstream Infection (CLABSI)
Rigshospitalet, Denmark 212
Not applicableUnknownNCT02946866
What this trial is testing

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

Who this might be right for
Cerebral Cavernous MalformationIntracerebral Hemorrhage
Seoul National University Hospital 228
Testing effectiveness (Phase 2)Study completedNCT02710253
What this trial is testing

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 214
Testing effectiveness (Phase 2)Study completedNCT00609869
What this trial is testing

Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab

Who this might be right for
Lymphocytic LeukemiaMantle Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 29
Large-scale testing (Phase 3)Ended earlyNCT01650805
What this trial is testing

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Who this might be right for
Chronic Myeloid Leukemia
Ariad Pharmaceuticals 307
Testing effectiveness (Phase 2)Study completedNCT00210756
What this trial is testing

Pharmacokinetic/ Pharmacodynamic Study of Epoetin Alfa (PROCRIT) in Critically Ill Patients.

Who this might be right for
AnemiaCritical Illness
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60
Not applicableUnknownNCT03673631
What this trial is testing

Oxygenation Methods and Non-invasive Ventilation in Patients With Acute Respiratory Failure and a do Not Intubate Order

Who this might be right for
Acute Respiratory FailureCancerHematologic Malignancy+2 more
Poitiers University Hospital 330
Testing effectiveness (Phase 2)Ended earlyNCT02943473
What this trial is testing

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Who this might be right for
High Risk Smoldering Multiple Myeloma
Icahn School of Medicine at Mount Sinai 9
Very early researchNot Yet RecruitingNCT06298266
What this trial is testing

To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Guangdong Second Provincial General Hospital 15
Early research (Phase 1)Study completedNCT02367456
What this trial is testing

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Pfizer 73
Not applicableStudy completedNCT03391622
What this trial is testing

Thrombin Generation Values and Percutaneous Coronary Intervention Results.

Who this might be right for
Coagulation DisorderIschemic Heart DiseaseArtery Coronary Stenosis
HaEmek Medical Center, Israel 128
Testing effectiveness (Phase 2)Ended earlyNCT01625741
What this trial is testing

Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Not applicableLooking for participantsNCT06692894
What this trial is testing

Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes, Adult
University of Vermont 30
Testing effectiveness (Phase 2)Looking for participantsNCT06083922
What this trial is testing

CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Who this might be right for
Multiple MyelomaMonoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04231851
What this trial is testing

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous Leukemia (AML) Due to TherapyAcute Myeloid Leukemia With Myelodysplasia-Related Changes
University of California, Irvine 30
Next Page